Free samples of Quit-Smoking drugs mailed to your door: does it work?
NCT ID NCT04525755
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether mailing free samples of varenicline (Chantix) or nicotine patches and lozenges helps smokers quit. 652 daily smokers were randomly assigned to receive a one-time sample of varenicline, nicotine replacement products, or no medication. Participants were not required to quit or use the samples. The study lasted 6 months and tracked smoking habits through surveys and daily diaries.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- varenicline (Chantix) and nicotine replacement therapy (patches and lozenges)
- What this could lead to
- If successful, this approach could make it easier for smokers to try quitting by offering free medication samples remotely, potentially increasing quit rates.
- What could go wrong
- This is an early-phase study with a relatively small sample. The results may not apply to all smokers, and participants were not required to quit, so the true effect on quitting is uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 1/2
Runs two stages together: safety and dose first, then whether the treatment works.
- Participants
-
652 people
The number who actually took part.
- Started
-
Feb 2021
- Finished
-
Apr 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Eligibility criteria include: 1. age 18+; 2. daily smoker (25+ days per previous month); 3. smoking 5+ cigarettes/day; 4. smoking \> 1yr; 5. some interest in eventual quitting (\>2 on 10-point scale); 6. has a primary care doctor and has seen that doctor at least once in past year; 7. not currently pregnant, breastfeeding, or planning to become pregnant; 8. no suicidal ideation in past month, nor any lifetime suicide attempt; 9. no reports of hallucinations; 10. no reports of history of seizures; nor cardiac/renal disease 11. own a smartphone or have regular (daily) access/use of email 12. if female, willing to take a pregnancy test 13. not currently taking any medications to help quit smoking 14. no diagnosis of schizophrenia or bipolar disorder 15. no members of the same household currently enrolled in the study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cigarette smoking are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Texts and wearables team up to help latinos quit smoking and get moving
- Can an AI chatbot help cancer patients kick the habit?
- Does the clock matter? scientists randomize when Quit-Smoking chatbots ping you
- Gum fluid proteins eyed as link between smoking and periodontitis
- Can a WhatsApp message help smokers quit?
- Practice quitting: a new way to help smokers who Aren't ready to stop?